Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. 2014

Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
Bezmialem Vakıf University Medical Faculty, Department of Pediatrics, İstanbul, Turkey. E-ma-il: dr.emeltorun@gmail.com.

OBJECTIVE We aimed to determine the association of thyroid functions with the components of metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD) in pediatric obese patients. METHODS The study included 109 obese children (aged 9-15 years) and a control group of 44 healthy age and gender-matched children of normal weight. NAFLD was diagnosed by conventional ultrasound examination. We assessed the anthropometric data and serum biochemical parameters including lipid profile, alanine aminotransferase (ALT), fasting glucose and insulin levels and thyroid stimulating hormone (TSH), free thyroxine (fT4) and free triiodothyronine (fT3) levels. The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as a measure of IR. RESULTS The mean age and gender distributions in the groups were similar (p=0.23). The mean body mass index (BMI) z-scores of obese children with grade 2-3 NAFLD were significantly higher than those of the obese children without hepatic steatosis (p<0.001). Mean ALT, triglyceride (TG) and LDL cholesterol increased and HDL-cholesterol significantly decreased as the hepatic steatosis increased (p<0.05). HOMA-IR levels in obese subjects with grade 2-3 NAFLD were significantly higher than those in both obese children without NAFLD and grade 1 NADFL (p=0.05 and 0.001, respectively). In the obese subjects, TSH levels were increased significantly as the degree of steatosis increased (p=0.04) but fT3 and fT4 levels were not different. In correlation analysis, TSH was significantly correlated with ALT, BMI SDS and the degree of steatosis. CONCLUSIONS Obese children demonstrate an increase in TSH levels as the degree of steatosis increased.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
April 2013, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz,
Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
September 2014, Journal of clinical research in pediatric endocrinology,
Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
October 2020, Hong Kong medical journal = Xianggang yi xue za zhi,
Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
October 2005, Endocrine journal,
Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
September 2015, Journal of clinical research in pediatric endocrinology,
Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
January 2018, Nutricion hospitalaria,
Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
April 2018, Pediatric gastroenterology, hepatology & nutrition,
Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
April 2010, Atherosclerosis,
Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
July 2017, Ugeskrift for laeger,
Emel Torun, and Ilker Tolga Özgen, and Selim Gökçe, and Sinem Aydın, and Yaşar Cesur
June 2014, Clinical biochemistry,
Copied contents to your clipboard!